Here are some news/notes from a day in MedCity, Minnesota:
EnteroMedics Inc. said Friday that its shares will now be listed on the Nasdaq Capital Market index instead of the Nasdaq Global Market index. The Roseville-based company, which is developing a device to treat obesity with neurostimulation, has seen its stock plummet in recent months after it reported trouble with its clinical trials. Last November, Nasdaq threatened to delist EnteroMedics because its stock failed to trade above $1.00 for ten consecutive days. The company has until May 12 to comply with the rule or face expulsion- again.
International Business Machines Corp. (IBM) and Mayo Clinic announced a new method to detect deadly brain aneurysms using analytics technology, which they say can provide detection with greater speed and accuracy, according to Dow Jones Newswire.
A high rate of falls in Minnesota nursing homes had lawmakers focusing Thursday on two issues — whether homes are understaffed and whether state health inspectors are being tough enough on them, according to the St. Paul Pioneer Press.
Mayo Clinic says it has been named to Fortune magazine’s annual 100 Best Places to Work list. The hospital ranked 55th. “The spirit of collaborative service that we all benefit from reflects the people who choose to be here, who bring integrity and compassion to their work every day,” Mayo CEO Dr. John Noseworthy said in a statement. “The past year has been a challenging one, but staff rose to that challenge. Their ideas, their energy and their teamwork made a significant difference in Mayo’s performance.”
